SATTE has always been a vital part of the Indian tourism industry and is recognised as the most sought after B2B travel and tourism event in South Asia. This year, SATTE has recorded an overwhelming participation of several Indian and global players, each visiting the event with high expectancy from the event and its offerings. Buyers and sellers continue to flock in, with their enthusiasm and support, fuelling a surge of first-time visitors and exhibitors as well.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64181-SATTE-2014-power-packed-year-for-travel
Extended Stay America – one of the largest owner operated hotel chains in the U.S., announced an exclusive partnership with The Noerr Programs, the premier provider of authentic Santa Experiences to nearly 300 of America’s top shopping centers. Extended Stay America hotels was hand-selected by The Noerr Programs and Santa Claus himself, for its comfort and home-like conveniences, and named “Santa’s Official Hotel,” while he travels away from the North Pole in his seasonal tradition of listening to children’s holiday dreams and wishes this season.
“We’re excited to partner with The Noerr Programs and Santa Claus, to help light up the holiday for travelers,” said Chief Marketing Officer, Tom Seddon. “Santa has been staying with us for years. As an iconic symbol of kindness and generosity, we believe Santa is perfectly aligned with our brand’s personality and the spirit you’ll find in our associates. During the holidays it is easy for travelers to get caught in the frenzy of the season and often times become stressed with balancing it all. Our Extended Stay America family, with a little magical help from Santa, looks to help ease holiday woes through the best way we know how -- extending the creature comforts of home so that guests can focus on enjoying time with loved ones and creating lasting memories.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7617751-extended-stay-santa-s-official-hotel/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
If you have a smartphone that downloads apps, you’re ready to hit the trail at J.N. “Ding” Darling National Wildlife Refuge (NWR) on Sanibel Island and utilize its latest innovation, which officials recently unveiled.
Designed to appeal to the next generation’s techie side and get them outside, the Refuge iNature Trail along Wildlife Drive has two components – one for kids and one for adults.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51155-j-n-ding-darling-national-wildlife-refuge-inature-trail
The Sanford Guide, recognized as the essential reference for infectious disease treatment, announced the release of its first mobile app for the iPhone, iPod touch and iPad. The Sanford Guide App, available on Apple’s App Store for $29.99, contains the comprehensive guidelines and recommendations featured in the well-known pocket-size guides used by health care professionals in treatment decision making for over 40 years.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sanfordguide/50808/
Samruk Kazyna, Kazakhstan’s sovereign wealth fund managing major strategic state assets with the combined value of close to $100 bn, is overhauling its business strategy, including approaches to investments and to asset management.
New management mechanisms will soon be introduced in all of the Fund’s companies. As early as 2014, business processes reengineering will start in three pilot organizations – diversified transport holding Kazakhstan Temir Zholy, oil and gas company KazMunaiGaz and postal service operator KazPochta.
These measured will result in operating costs reduction of 20% by 2017, and Samruk Kazyna’s economic value added will generate more than $11.2 bn for Kazakhstan’s economy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762559-samruk-kazyna-transformation-forum/
On February 26, the Salt Institute unveiled a unique advertising campaign featuring a new character for its brand: Olde Salty.
This salt-of-the-earth character is the newest ideation from advertising agency Grey San Francisco. The campaign features a series of videos in which the post-nautical sage slides across icy roads, shares virgin tequila shots, and even feeds his pet clam a few dashes of the institute's favorite mineral. It’s a well-balanced blend of entertainment and the benefits of one the world’s most versatile and savory products—and it's nothing short of white gold.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7458351-olde-salty-conversation-salt/
On February 26, the Salt Institute unveiled a unique advertising campaign featuring a new character for its brand: Olde Salty.
This salt-of-the-earth character is the newest ideation from advertising agency Grey San Francisco. The campaign features a series of videos in which the post-nautical sage slides across icy roads, shares virgin tequila shots, and even feeds his pet clam a few dashes of the institute's favorite mineral. It’s a well-balanced blend of entertainment and the benefits of one the world’s most versatile and savory products—and it's nothing short of white gold.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7458351-olde-salty-conversation-salt/
In recognition of International Women’s Day, Avon Foundation for Women Ambassador Salma Hayek Pinault and Avon Products, Inc. CEO Sheri McCoy announced that four global organizations and one government campaign have received 2nd Avon Communications Awards: Speaking Out About Violence Against Women for their outstanding work to bring attention to the need to end violence against women. The awards, presented at the United Nations Headquarters during the 57th session of the Commission on the Status of Women, are part of the Avon Speak Out Against Domestic Violence program, which has donated nearly $50 million globally to end violence against women since its launch in 2004.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60518-salma-hayek-pinault-presents-2nd-avon-global-communications-awards
Saint Francis and the Nativity is an engaging story that weaves together the history of the first nativity with the fictional story of a young shepherd boy, who helps Saint Francis of Assisi find a way to visually display the true meaning of Christmas. There are suggested family activities in the back of the book. Learn more about the book here: http://bit.ly/9YOCB8 and its author here: http://bit.ly/9rI4f5 and its illustrator here: http://bit.ly/db8sR1
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
